Shots: The company reported the positive findings of a pooled analysis of six ongoing clinical studies which includes P-IIb/IIIb LATTE-2, ATLAS, ATLAS-2M, FLAIR, POLAR, and CUSTOMIZE studies evaluating long-acting cabotegravir […]readmore
Tags : ATLAS
Shots: The P-III ATLAS (n= 616) & FLAIR (n= 566) studies involve assessing of Rilpivirine + Cabotegravirin vs oral HIV therapies in virally suppressed HIV patients The ATLAS (NCT02951052) & […]readmore